title: Omalizumab in persistent severe bakers' asthma.
authors.affiliation: Department of Medicine and Public Health, Unit of Occupational Medicine, University of Verona, Policlinico G. Rossi, Piazza L.A. Scuro, 1037134 Verona, Italy. mario.olivieri@univr.it
authors.forename: M
authors.initials: M
authors.lastname: Olivieri
authors.forename: C A
authors.initials: CA
authors.lastname: Biscardo
authors.forename: S
authors.initials: S
authors.lastname: Turri
authors.forename: L
authors.initials: L
authors.lastname: Perbellini
mesh_terms: D000485:Allergens / Q000276:immunology; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000188:drug therapy* / Q000276:immunology; D000069444:Omalizumab; D012882:Skin Tests; D021182:Wheat Hypersensitivity / Q000188:drug therapy* / Q000276:immunology
chemical_list: D000485:Allergens; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E